logo image
search icon
Primary Cells Market

Primary Cells Market Size, Share & Trends Analysis Report By Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), By Origin (Human Primary Cells, Animal Primary Cells), By End-User, By Region, And By Segment Forecasts, 2023-2031.

Report ID : 2112 | Published : 2024-10-18 | Pages: 179 | Format: PDF/EXCEL

Primary Cells Market Size is valued at USD 1.63 Bn in 2022 and is predicted to reach USD 3.91 Bn by the year 2031 at a 10.4% CAGR during the forecast period for 2023-2031.

Primary Cells Market

Primary cells are cells isolated from a living organism as opposed to "cell lines," which have been grown for a long time and are frequently employed in various biological and medical research purposes. Because they more closely resemble cells in living organisms and provide a more precise depiction of cell behaviour, operation, and responses to stimuli than immortalized cell lines, human primary cells are in high demand by research institutes and pharmaceutical companies for developing potential cancer medicines and treatments.

In addition, Growth in the pharmaceutical and biotechnology sectors, rising demand for monoclonal antibodies, increasing government investments in cell-based research, and growing interest in cancer treatment are all factors driving the expansion of this market. More in-depth studies using primary cells by researchers and drug development companies have become possible thanks to developments in automation, single-cell analysis, and imaging technologies, and these developments, along with infrastructure improvements, are expected to stoke the market's Growth over the next few years.

However, the market expansion may be hampered by the scarcity of particular cell types and fresh samples due to cell source restrictions and a short lifespan in culture. In addition, the primary cell market benefited from COVID-19. Researchers study the infection and develop standardized epithelial cell culture models using primary cell culture. These models can help replicate the characteristics of the respiratory system, which could lead to important medical discoveries.

Furthermore, there has been a rise in the isolation of primary cells for treating various illnesses. Private organizations, biotech firms, and government bodies have all increased their focus and funding on these technologies as they find more and more uses in healthcare. Primary cell cultures are becoming increasingly popular for viral synthesis, which is utilized to produce a wide variety of vaccines.

Competitive Landscape

Some Major Key Players In The Primary Cells Market:

  • Thermo Fisher Scientific, Inc.
  • Merck KgAa
  • Corning Incorporated
  • Lonza Group
  • Charles River Laboratories, Inc.
  • PromoCell Gmbh
  • American Type Culture Collection (ATCC)
  • Cell Biologics, Inc.
  • Zen-Bio, Inc.
  • Stemcell Technologies, Inc.
  • AllCells
  • iXCells Biotechnologies
  • Neuromics
  • Axol Bioscience Ltd.
  • StemExpress
  • Bioivt
  • ScienCell Research Laboratories, Inc.
  • AMSBIO
  • ProMab Biotechnologies, Inc.
  • Creative Bioarray
  • Bps Bioscience, Inc.
  • Epithelix
  • Reachbio Research Labs
  • AcceGen
  • Kosheeka
  • Others

Market Segmentation:

The primary cells market is segmented based on type, origin and end-user. Based on type, the market is segmented into hematopoietic, dermatocytes, hepatocytes, gastrointestinal, lung, renal, heart, and musculoskeletal. By origin, the market is segmented into human primary cells and animal primary cells. By end user, the market is segmented into life science research companies, research institutes, and others.

Based On The Type, The Hematopoietic Primary Cells Market Segment Is Accounted As A Major Contributor To The Primary Cells Market. 

The hematopoietic primary cells category is expected to hold a major global market share due to the rising prevalence of blood malignancies and other immune system illnesses, as well as factors such as the use of Hematopoietic cell transplants and the research and development of novel cancer medicines. The largest projected growth rate is anticipated for hepatocytes because of their rising demand in toxicological and pharmacological research.

Human Primary Cells Segment To Witness Growth At A Rapid Rate.

The human primary cells segment is projected to grow rapidly in the global Primary Cells market. Human primary cells have been used extensively in cancer cell research and toxicity. Demand for reliable disease models, progress in research and drug discovery, the emergence of regenerative medicine, the need for rigorous safety testing, the growing prevalence of chronic diseases, technological advances, ethical considerations, and scientific collaborations are all factors propelling the human market forward, especially in countries like the US, Germany, the UK, China, and India.

In The Region, The North America Primary Cells Market Holds A Significant Revenue Share.

The North America primary cells market activity is anticipated to record the largest market share in revenue in the near future. It can be attributed to because of the high price of healthcare, the growing number of elderly, the increasing incidence of chronic diseases, and the money provided by the government.

Furthermore, growing interest in gene therapy, the availability of new research tools, and the expansion of the field all contribute to the size of the market in the United States. In addition, Asia Pacific is projected to grow rapidly in the global primary cells market due to the industry's focus on developing innovative applications for cultivating cells, improving its instruments, expanding its repertoire of cell kinds, and studying the intercellular interactions between them. 

Recent Developments:

  • In March 2023, Thermo Fisher Scientific established a cell therapy facility at the (UCSF) to expedite the advancement of innovative therapeutic interventions. The anticipated collaboration between Thermo Fisher and UCSF in 2021 presented an opportunity to explore the hypothesis that the proximity of scientists, doctors, and patients to a manufacturing facility could enhance the efficiency of breakthrough drug development.
  • In Aug 2023, The recent announcement by the business indicates that the Phase III LITESPARK-005 research demonstrated that Merck's Welireg (belzutifan) successfully achieved its primary objective of a significant enhancement in progression-free survival for patients diagnosed with advanced renal cell carcinoma.

Primary Cells Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 1.63 Bn

Revenue Forecast In 2031

USD 3.91 Bn

Growth Rate CAGR

CAGR of 10.4 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Type, Origin, End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Thermo Fisher Scientific, Inc., Merck Kgaa, Corning Incorporated, Lonza Group, Charles River Laboratories, Inc., Promocell Gmbh, American Type Culture Collection (ATCC), Cell Biologics, Inc., Zenbio, Inc., Stemcell Technologies, Inc., Allcells, Ixcells Biotechnologies, Neuromics, Axol Bioscience Ltd., Stemexpress, Bioivt, Sciencell Research Laboratories, Inc., Amsbio, Promab Biotechnologies, Inc., Creative Bioarray, Bps Bioscience, Inc., Epithelix, Reachbio Research Labs, Accegen, Kosheeka and Others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Primary Cells Market Snapshot

Chapter 4. Global Primary Cells Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis

5.1. By Type, & Market Share, 2020 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type:

5.2.1. Hematopoietic,

5.2.2. Dermatocytes,

5.2.3. Hepatocytes,

5.2.4. Gastrointestinal,

5.2.5. Lung,

5.2.6. Renal,

5.2.7. Heart,

5.2.8. Musculoskeletal

Chapter 6. Market Segmentation 2: By Origin Estimates & Trend Analysis

6.1. By Origin & Market Share, 2020 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Origin:

6.2.1. Human Primary Cells,

6.2.2. Animal Primary Cells

Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis

7.1. By End User & Market Share, 2020 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:

7.2.1. Life Science Research Companies,

7.2.2. Research Institutes,

7.2.3. Others

Chapter 8. Primary Cells Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Primary Cells Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031

8.1.2. North America Primary Cells Market revenue (US$ Million) estimates and forecasts By Origin, 2019-2031

8.1.3. North America Primary Cells Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031

8.1.4. North America Primary Cells Market revenue (US$ Million) estimates and forecasts by country, 2019-2031

8.2. Europe

8.2.1. Europe Primary Cells Market revenue (US$ Million) By Type, 2019-2031

8.2.2. Europe Primary Cells Market revenue (US$ Million) By Origin, 2019-2031

8.2.3. Europe Primary Cells Market revenue (US$ Million) By End User, 2019-2031

8.2.4. Europe Primary Cells Market revenue (US$ Million) by country, 2019-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Primary Cells Market revenue (US$ Million) By Type, 2019-2031

8.3.2. Asia Pacific Primary Cells Market revenue (US$ Million) By Origin, 2019-2031

8.3.3. Asia Pacific Primary Cells Market revenue (US$ Million) By End User, 2019-2031

8.3.4. Asia Pacific Primary Cells Market revenue (US$ Million) by country, 2019-2031

8.4. Latin America

8.4.1. Latin America Primary Cells Market revenue (US$ Million) By Type, (US$ Million) 2019-2031

8.4.2. Latin America Primary Cells Market revenue (US$ Million) By Origin, (US$ Million) 2019-2031

8.4.3. Latin America Primary Cells Market revenue (US$ Million) By End User, (US$ Million) 2019-2031

8.4.4. Latin America Primary Cells Market revenue (US$ Million) by country, 2019-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Primary Cells Market revenue (US$ Million) By Type, (US$ Million) 2019-2031

8.5.2. Middle East & Africa Primary Cells Market revenue (US$ Million) By Origin, (US$ Million) 2019-2031

8.5.3. Middle East & Africa Primary Cells Market revenue (US$ Million) By End User, (US$ Million) 2019-2031

8.5.4. Middle East & Africa Primary Cells Market revenue (US$ Million) by country, 2019-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Thermo Fisher Scientific, Inc.

9.2.2. Merck KgAa

9.2.3. Corning Incorporated

9.2.4. Lonza Group

9.2.5. Charles River Laboratories, Inc.

9.2.6. PromoCell Gmbh

9.2.7. American Type Culture Collection (ATCC)

9.2.8. Cell Biologics, Inc.

9.2.9. Zen-Bio, Inc.

9.2.10. Stemcell Technologies, Inc.

9.2.11. AllCells

9.2.12. iXCells Biotechnologies

9.2.13. Neuromics

9.2.14. Axol Bioscience Ltd.

9.2.15. StemExpress

9.2.16. Bioivt

9.2.17. ScienCell Research Laboratories, Inc.

9.2.18. AMSBIO

9.2.19. ProMab Biotechnologies, Inc.

9.2.20. Creative Bioarray

9.2.21. Bps Bioscience, Inc.

9.2.22. Epithelix

9.2.23. Reachbio Research Labs

9.2.24. AcceGen

9.2.25. Kosheeka

9.2.26. Others

Segmentation of Primary Cells Market-

Primary Cells Market By Type -

  • Hematopoietic
  • Dermatocytes
  • Hepatocytes
  • Gastrointestinal
  • Lung
  • Renal
  • Heart
  • Musculoskeletal

Primary Cells Market Seg

Primary Cells Market By Origin -

  • Human Primary Cells
  • Animal Primary Cells

Primary Cells Market By End User -

  • Life Science Research Companies
  • Research Institutes
  • Others Improve

Primary Cells Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Primary Cells Market Size?

Primary Cells Market is expected to grow at a 10.4% CAGR during the forecast period for 2023-2031.

Amsbio, Promab Biotechnologies, Inc., Creative Bioarray, Bps Bioscience, Inc., Epithelix, Reachbio Research Labs, Accegen, Kosheeka and Others

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Biotechnology

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach